Development of PF-06671008, a Highly Potent Anti-P-cadherin/Anti-CD3 Bispecific DART Molecule with Extended Half-Life for the Treatment of CancerLaird Bloom, Caryl Meade, Jocelyn Sanford et al.|Antibodies|2016Cited by 94
IgG antibodies produced during subcutaneous allergen immunotherapy mediate inhibition of basophil activation via a mechanism involving both FcγRIIA and FcγRIIBCarol Cady, John C. Cambier, Maree S. Powell et al.|Immunology Letters|2009Cited by 87